IDEX ASA issues this notice on behalf of the primary insiders below. Certain
primary insiders acquired shares in IDEX ASA by participating in the private
placement of shares on 30 January 2019.

The primary insiders will acquire shares at NOK 4.00 per share, the same price
as the other investors participating in the private placement.

Chairman Morten Opstad, through a close associate, will acquire 100,000 shares.
After this transaction, Mr. Opstad and close associates will hold 7,298,916
shares in IDEX. Mr. Opstad or his close associates do not hold any other rights
to shares in IDEX.

Board member Andy MacLeod will acquire 140,000 shares. After this transaction,
Mr. MacLeod will hold 693,475 shares and 500,000 incentive subscription rights
in IDEX.

CEO Stan Swearingen will acquire 250,000 shares. After this transaction, Mr.
Swearingen will hold 400,000 shares and 6,815,000 incentive subscription rights
in IDEX.

CFO Henrik Knudtzon will acquire 100,000 shares. After this transaction, Mr.
Knudtzon will hold 150,000 shares and 2,290,000 incentive subscription rights in
IDEX.

30 January 2019

IDEX ASA


For further information contact:
Henrik Knudtzon, CFO
+47 9302 2827

Stuart Hunt, Head of Investor Relations & Communications
+44 1276 534 632

About IDEX Biometrics
IDEX Biometrics, legal name IDEX ASA (OSE: IDEX), is the leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity, gain
access to information, unlock devices or gain admittance to buildings with the
touch of a finger. We invent, engineer and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast-growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.